TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35701242

Group type: EXPERIMENTAL
Intervention: Posture-cueing shirt
Number of subjects: 30

Group type: COMPARATOR
Intervention: No shirt
Number of subjects: 30

Group type: COMPARATOR
Intervention: Compression shirt
Number of subjects: 30
Study: 32048336

Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) study
Number of subjects: 0
Study: 35107239

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) treatment for ovarian rejuvenation
Number of subjects: 0
Study: 32122322

Group type: EXPERIMENTAL
Intervention: Tailored leaflet intervention
Number of subjects: 129

Group type: COMPARATOR
Intervention: Usual care control (no leaflet)
Number of subjects: 129
Study: 34533973

Group type: EXPERIMENTAL
Intervention: FU/FA plus Pmab
Number of subjects: 248

Group type: COMPARATOR
Intervention: FU/FA alone
Number of subjects: 248
Study: 32306634

Group type: EXPERIMENTAL
Intervention: Noise-exposure + doxycycline (50 mg/kg/d for 4 consecutive days)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Noise-exposure (120 dB SPL white noise for 4 h per day for 2 consecutive days)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Normal control (0.9% saline for 4 consecutive days)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Noise-exposure + doxycycline
Number of subjects: 45

Group type: COMPARATOR
Intervention: Noise-exposure
Number of subjects: 45
Study: 33543266

Group type: EXPERIMENTAL
Intervention: Denneroll cervical traction
Number of subjects: 110

Group type: COMPARATOR
Intervention: Multimodal program (Control)
Number of subjects: 110
Study: 33028101

Group type: EXPERIMENTAL
Intervention: PZ‐128 (0.3 or 0.5 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PZ‐128 (combined doses)
Number of subjects: 100
Study: 35021600

Group type: EXPERIMENTAL
Intervention: Follicular lymphoma grade 3B with coexisting diffuse large B-cell lymphoma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Follicular lymphoma grade 3B without coexisting diffuse large B-cell lymphoma
Number of subjects: 0
Study: 33787625

Group type: EXPERIMENTAL
Intervention: Sugar-free gum, chewed for 6 hours post-surgery until first intestinal gas release
Number of subjects: 74

Group type: COMPARATOR
Intervention: Water consumption after 6 hours post-surgery
Number of subjects: 74
Study: 34549852

Group type: EXPERIMENTAL
Intervention: Culturally non-adapted unguided internet-based sleep intervention (3 modules on sleep hygiene and cognitive techniques)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 81
Study: 33208752

Group type: EXPERIMENTAL
Intervention: SAFER pregnancy intervention (monthly group sessions, web-based platform, incentives for cessation)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: SAFER pregnancy intervention
Number of subjects: 66
Study: 35121638

Group type: EXPERIMENTAL
Intervention: Electronic monitoring feedback (EMF) with a Medication Event Monitoring System (MEMS) cap and motivational interviewing feedback.
Number of subjects: 206

Group type: COMPARATOR
Intervention: Usual care (Control group).
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Electronic monitoring feedback (EMF) for bDMARD-naive patients.
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Electronic monitoring feedback (EMF).
Number of subjects: 206
Study: 33811783

Group type: EXPERIMENTAL
Intervention: Plasma neurofilament light chain (NfL) levels
Number of subjects: 115
Study: 32540806

Group type: EXPERIMENTAL
Intervention: Low glycemic index/high-fat, high-calorie diet
Number of subjects: 44

Group type: COMPARATOR
Intervention: High-fat, high-calorie diet
Number of subjects: 44
Study: 35113809

Group type: EXPERIMENTAL
Intervention: Topical metronidazole treatment
Number of subjects: 0
Study: 33158697

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 12806

Group type: COMPARATOR
Intervention: Non-montelukast
Number of subjects: 12806
Study: 32128884

Group type: EXPERIMENTAL
Intervention: DBBM-C/CM
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DBBM-C
Number of subjects: 36

Group type: COMPARATOR
Intervention: Spontaneous Healing (SH)
Number of subjects: 36
Study: 35130768

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 132
Study: 34422076

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 60
Study: 34292430

Group type: EXPERIMENTAL
Intervention: Family planning support intervention
Number of subjects: 320
Study: 34331914

Group type: EXPERIMENTAL
Intervention: Chemoembolization
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Yttrium‐90 radioembolization
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Initial downstaging procedure
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Post-LT survival
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: HCC recurrence
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Sum of the number of lesions plus largest tumor diameter on the last pre‐LT imaging
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Pretreatment with lectin-reactive ?-fetoprotein ?10%
Number of subjects: 209
Study: 35981712

Group type: EXPERIMENTAL
Intervention: blackcurrant + caffeine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: blackcurrant + placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: caffeine + placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo + placebo
Number of subjects: 12
Study: 33174483

Group type: EXPERIMENTAL
Intervention: tDCS at 1.0 mA
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: tDCS at 0.7 mA
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: tDCS at 2.0 mA
Number of subjects: 123

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 123
Study: 36378018

Group type: EXPERIMENTAL
Intervention: Needle-free insulin injector (NFII)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional insulin pen (CIP)
Number of subjects: 48
Study: 32162352

Group type: EXPERIMENTAL
Intervention: Intravenous vitacoxib (0.1 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral paste vitacoxib (0.1 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral tablet vitacoxib (0.1 mg/kg)
Number of subjects: 6
Study: 33678253

Group type: EXPERIMENTAL
Intervention: Frequent moisturizer use
Number of subjects: 1303
Study: 35796481

Group type: EXPERIMENTAL
Intervention: Sodium oxybate (3.3-3.9 g/day)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study: 34142950

Group type: EXPERIMENTAL
Intervention: Generic clozapine (ChangZhou Pharmaceutical Factory Co. Ltd.) 100 mg twice daily for 10 days
Number of subjects: 26

Group type: COMPARATOR
Intervention: Clozaril (HLS Therapeutics, Inc.) 100 mg twice daily for 10 days
Number of subjects: 26
Study: 32301812

Group type: EXPERIMENTAL
Intervention: Slow speed stripping (group 1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fast speed stripping (group 2)
Number of subjects: 20
Study: 36018883

Group type: EXPERIMENTAL
Intervention: Dynamic needle tip positioning (DNTP)
Number of subjects: 151
Study: 32157905

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 200

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 200
Study: 34514626

Group type: EXPERIMENTAL
Intervention: Perception of CHNA as 'not troublesome' or 'not impossible as they learned'
Number of subjects: 3397

Group type: EXPERIMENTAL
Intervention: Continuing education with 5 years of experience
Number of subjects: 3397

Group type: EXPERIMENTAL
Intervention: Identification of the learned model in continuing education
Number of subjects: 3397

Group type: EXPERIMENTAL
Intervention: Reasons for non-utilization of the model
Number of subjects: 3397
Study: 33308949

Group type: EXPERIMENTAL
Intervention: Dorsal Inlay Graft Urethroplasty (DIGU)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Longitudinal Onlay Preputial Flap (LOF)
Number of subjects: 39
Study: 35610366

Group type: COMPARATOR
Intervention: E-T-CMF (Control Arm A)
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: E-CMF-wD (Arm B)
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: E-CMF-wT (Arm C)
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: Trastuzumab administration
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 990
Study: 33189637

Group type: EXPERIMENTAL
Intervention: Telecytology quality assurance program
Number of subjects: 1983
Study: 36040069

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control (standard of care)
Number of subjects: 210
Study: 34706374

Group type: EXPERIMENTAL
Intervention: TEA1 (1000 mL with approximately 200,000 µg silicon/L)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TEA2 (1000 mL with approximately 750,000 µg silicon/L)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Si-low-Water (approximately 10-10,000 µg silicon/L as a control)
Number of subjects: 12
Study: 33998393

Group type: EXPERIMENTAL
Intervention: Pilates exercises
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Aerobic exercises
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 33451926

Group type: EXPERIMENTAL
Intervention: Alfaxalone (15 mg kg−1) and midazolam (2 mg kg−1) with flumazenil (0.3 mg kg−1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Alfaxalone (15 mg kg−1) and midazolam (2 mg kg−1) with saline
Number of subjects: 10
Study: 32779560

Group type: EXPERIMENTAL
Intervention: Rare indications
Number of subjects: 96

Group type: COMPARATOR
Intervention: Non-rare indications
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Funding time
Number of subjects: 96
Study: 35633281

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (details not specified)
Number of subjects: 157
Study: 32945236

Group type: EXPERIMENTAL
Intervention: Agrochemical health education intervention
Number of subjects: 480

Group type: COMPARATOR
Intervention: Inappropriate time of spray
Number of subjects: 480

Group type: COMPARATOR
Intervention: Frequency of spray
Number of subjects: 480

Group type: COMPARATOR
Intervention: Long hours of daily chemical spray
Number of subjects: 480

Group type: COMPARATOR
Intervention: Non-usage of chemical labels
Number of subjects: 480
Study: 32101915

Group type: EXPERIMENTAL
Intervention: Biopsy first (group A)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Brushings first (group B)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Combination (group C)
Number of subjects: 54
Study: 34718171

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (HT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard medical treatment (SMT)
Number of subjects: 100
Study: 33634706

Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation
Number of subjects: 346
Study: 35109685

Group type: EXPERIMENTAL
Intervention: Intensive treatment group (ΔSBP15-60M)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Intensive treatment group (ΔSBP6-24H)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 267
Study: 32060747

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy with 3D visualization technology
Number of subjects: 135

Group type: COMPARATOR
Intervention: Laparoscopic appendectomy with standard 2D technology
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy with 3D visualization technology (subgroup of complicated appendicitis)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Laparoscopic appendectomy with standard 2D technology (subgroup of complicated appendicitis)
Number of subjects: 135
Study: 35697450

Group type: EXPERIMENTAL
Intervention: Personalised education using a smart spacer (Aerochamber Plus with Flow Vu) for 1 month
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall feasibility of a definitive trial
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patient and healthcare provider satisfaction
Number of subjects: 40
Study: 32721163

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) for weight loss
Number of subjects: 134

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 134
Study: 32319514

Group type: EXPERIMENTAL
Intervention: Special home visiting support
Number of subjects: 1510
Study: 35870556

Group type: EXPERIMENTAL
Intervention: Coronary Angiography (CAG)
Number of subjects: 24
Study: 33984038

Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 275
Study: 36394733

Group type: EXPERIMENTAL
Intervention: Methylene blue photosensitizer (MBP) + MTAD
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rose Bengal photosensitizer (RBP) + MTAD
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Curcumin photosensitizer (CP) + MTAD
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2.25% NaOCl + MTAD
Number of subjects: 40
Study: 33676727

Group type: EXPERIMENTAL
Intervention: Inhaled methoxyflurane 3 ml
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fentanyl 25 μg i.v.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fentanyl 50 μg i.v.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 12
Study: 34698342

Group type: EXPERIMENTAL
Intervention: Free distribution of oral rehydration salts (ORS) via home deliveries prior to diarrhea onset
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Free distribution of ORS via vouchers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Door-to-door sales model (home sales)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm (normal activities of CHWs)
Number of subjects: 0
Study: 35385542

Group type: EXPERIMENTAL
Intervention: Intervention 1 using both mobile platform and MCH
Number of subjects: 3002

Group type: EXPERIMENTAL
Intervention: Intervention 2 using MCH alone
Number of subjects: 3002

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3002

Group type: EXPERIMENTAL
Intervention: Neonatal mortality rate with CoC
Number of subjects: 3002

Group type: EXPERIMENTAL
Intervention: Neonatal mortality rate without CoC
Number of subjects: 3002
Study: 33452340

Group type: EXPERIMENTAL
Intervention: Active group (HF-rTMS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 40
Study: 32045441

Group type: EXPERIMENTAL
Intervention: Alanine transaminase (ALT)
Number of subjects: 3455

Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (ALP)
Number of subjects: 3455

Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) estimates for ALT
Number of subjects: 3455

Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (ALP) and gamma glutamyltransferase (GGT)
Number of subjects: 3455
Study: 36138388

Group type: EXPERIMENTAL
Intervention: Computer-controlled local anesthesia (CCLA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional local anesthesia (LA)
Number of subjects: 60
Study: 32586428

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Treatment for Insomnia (BBTI)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTI)
Number of subjects: 63
Study: 33550193

Group type: EXPERIMENTAL
Intervention: Rosemary essential oil inhalation (1 drop using a mask)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Distilled water (control group)
Number of subjects: 80
Study: 35468032

Group type: EXPERIMENTAL
Intervention: Group A: misoprostol 400 mcg vaginally and pyridoxine 40 mg sublingually
Number of subjects: 140

Group type: COMPARATOR
Intervention: Group B: misoprostol 400 mcg sublingually and pyridoxine 40 mg vaginally
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 140
Study: 32857643

Group type: EXPERIMENTAL
Intervention: Discussion guide
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard education material
Number of subjects: 100
Study: 33220066

Group type: EXPERIMENTAL
Intervention: High-dose flumazenil (20 µg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Low-dose flumazenil (10 µg/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6
Study: 35340231

Group type: EXPERIMENTAL
Intervention: 35 laser shots
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 45 laser shots
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 60 laser shots
Number of subjects: 55
Study: 34543864

Group type: EXPERIMENTAL
Intervention: Osimertinib with carboplatin and pemetrexed
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Osimertinib with cisplatin and pemetrexed
Number of subjects: 30
Study: 33529081

Group type: EXPERIMENTAL
Intervention: LEM5 treatment (5 g lemongrass/ewe/d)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: LEM10 treatment (10 g lemongrass/ewe/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (without supplement)
Number of subjects: 30
Study: 32208898

Group type: EXPERIMENTAL
Intervention: Mental illness (schizophrenia)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Mental illness (alcohol dependency)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Mental illness (depression)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Control (no mental illness)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Presence of mental illness (MI)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Type of mental illness
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Familiarity with MI and criminality
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Perceived race of the person
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Perceived MI severity
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Likelihood of rehabilitation
Number of subjects: 290
Study: 36270197

Group type: EXPERIMENTAL
Intervention: Culturally adapted motivational interviewing (CAMI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unadapted motivational interviewing (MI)
Number of subjects: 0
Study: 33531693

Group type: EXPERIMENTAL
Intervention: Targeted intraoperative radiotherapy (TARGIT‐IORT) during lumpectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole-breast external beam radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 0
Study: 35080713

Group type: EXPERIMENTAL
Intervention: Text messaging intervention for cannabis use disorder
Number of subjects: 47
Study: 34012064

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg/day)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg/day)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88

Group type: COMPARATOR
Intervention: Liraglutide vs Placebo
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sitagliptin vs Placebo
Number of subjects: 88
Study: 34848381

Group type: EXPERIMENTAL
Intervention: VP250 (250‐μg peanut protein)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: VP250
Number of subjects: 393
Study: 34974573

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Milligan Morgan technique
Number of subjects: 60
Study: 35193872

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg plus MTX
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 0
Study: 32400190

Group type: EXPERIMENTAL
Intervention: Fully-matched message frame condition
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Valence-matched message frame condition
Number of subjects: 147

Group type: COMPARATOR
Intervention: Unmatched message frame condition
Number of subjects: 147
Study: 33917987

Group type: EXPERIMENTAL
Intervention: High frequency protein-rich meal service (six protein-rich dishes per day)
Number of subjects: 102
Study: 34032906

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 60
Study: 34511891

Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol (5 μg/5 μg)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 35958815

Group type: EXPERIMENTAL
Intervention: Exercise intervention group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nutrition intervention group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sports nutrition intervention group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 32659982

Group type: EXPERIMENTAL
Intervention: Breakfast consumption groups (BCG)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Skipping breakfast
Number of subjects: 671
Study: 35007188

Group type: EXPERIMENTAL
Intervention: BCG vaccination (BCG-Denmark, BCG-Japan, BCG-Russia)
Number of subjects: 214
Study: 34189981

Group type: EXPERIMENTAL
Intervention: B12 fortified nutrient bar (2 μg)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: B12 fortified yogurt (2 μg)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282

Group type: COMPARATOR
Intervention: Propionibacterium (1 × 10^8 cfu/g)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: B12 supplementation (in both trials)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Anthropometry and hemoglobin measurements
Number of subjects: 282
Study: 36169579

Group type: EXPERIMENTAL
Intervention: Family Talk Intervention (FTI)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Let's Talk about Children (LTC)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Interventions as Usual (IAU)
Number of subjects: 89
Study: 33427870

Group type: EXPERIMENTAL
Intervention: Oral moxifloxacin (400 mg/d for 7 days)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Intravenous ertapenem (1 g/d for 2 days) followed by oral levofloxacin (500 mg/d) and metronidazole (500 mg 3 times/d for 5 days)
Number of subjects: 599
Study: 32434490

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment
Number of subjects: 158
Study: 34006174

Group type: EXPERIMENTAL
Intervention: Breathing meditation
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Body-scan meditation
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: High equanimity
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Low equanimity
Number of subjects: 155

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 155